.
MergerLinks Header Logo

Announced

Completed

Gilead-backed Kite completed the acquisition of Tmunity Therapeutics.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

Friendly

Acquisition

Single Bidder

health care

Majority

Biotechnology

Domestic

United States

biotechnology

genetics

Completed

Synopsis

Edit

Gilead-backed Kite, a global biopharmaceutical company, completed the acquisition of Tmunity Therapeutics, a clinical-stage, private biotech company. Financial terms were not disclosed. “Kite has demonstrated an ability to globally scale cell therapy and address the unique challenges and opportunities that cell therapy represents, which are quite different in material ways than traditional pharmaceutical or biotech approaches. Kite’s singular focus on cell therapy makes them unique and particularly nimble,” Carl June, Tmunity Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US